GeneDx (NASDAQ:WGS – Get Free Report) and Astrana Health (NASDAQ:ASTH – Get Free Report) are both healthcare companies, but which is the superior investment? Analyst RatingsThis is a breakdown of recent recommendations for GeneDx and Astrana Health, as provided by MarketBeat. Given Astrana Health’s stronger consensus rating and higher possible upside, analysts clearly believe Astrana Health is more favorable than GeneDx. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. GeneDx is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.